Ledger.Open graph →
SEC Form D · filed August 11, 2023

Better Therapeutics, Inc

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Mark Heinen · San Francisco, CAExecDavid Perry · San Francisco, CAExec · DirectorKristin Wynholds · San Francisco, CAExecFrank Karbe · San Francisco, CAExec · DirectorGeoffrey Parker · San Francisco, CADirectorRisa Lavizzo-Mourey · San Francisco, CADirectorRichard Carmona · San Francisco, CADirectorElder Granger · San Francisco, CADirectorMark Berman · San Francisco, CAExecAndrew Armanino · San Francisco, CADirectorCatharine Thurston · Knoxville, TNDirectorHash3 Capital GP II LLC · Ridgefield, CTDirectorMilind O. Joshi · Mumbai, K7DirectorJinping O. Sun · Central Hong Kong, Hong KongDirectorAlan P. Rutledge · Miami, FLDirectorJavier O. Okhuysen · Mexico City, O5Exec · DirectorPareto Captive of Tennessee LLC · Knoxville, TNExecChiranjeevi P. Banala · Miami, FLExecWill Bondurant · Knoxville, TNExecPawan K. Chandana · Miami, FLExec · DirectorSharmila M. Kassam · Austin, TXExec · DirectorMonica M. Medina · Austin, TXDirectorJennifer M. Wenzel · Austin, TXDirectorPrintice M. Gary · Austin, TXDirectorBeverly M. Grass · Austin, TXExecAshton M. Cumberbatch · Austin, TXExecDavid M. Steinwedell · Austin, TXDirectorBrian M. Strickland · Austin, TXDirectorMarianne M. Dwight · Austin, TXExec · DirectorPatrick Clancy · Redwood City, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗